T-cell Based Immunotherapy for of Melanoma

Clinical Trial ID NCT00937625

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
2	Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.	J Transl Med	2012	1.06
3	Effector CD4 and CD8 T cells and their role in the tumor microenvironment.	Cancer Microenviron	2012	1.05
4	Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.	Clin Cancer Res	2016	1.01
5	Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion.	J Invest Dermatol	2012	0.98
6	Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.	Oncoimmunology	2012	0.82
7	Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.	Nat Biotechnol	2016	0.81
8	Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.	Hum Vaccin Immunother	2015	0.77